Patents by Inventor Peter Tobias

Peter Tobias has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of preparing a polymer, method of preparing a compound, compounds, polymers, and method of manufacturing an electronic device
    Publication number: 20030027963
    Abstract: A polymer comprising structural units of the formula I is prepared according to a novel method, in which the starting compound R1 ‘S—(CHR’2) —Ar— (CHR2)—SR1 is polymerized with a base, preferably in an aprotic solvent. The polymer comprises 50 to 1000 structural units of the formula I. The solution comprising the polymer thus prepared has a lower viscosity than a solution of a similar polymer with a greater chain length. The solution comprising the polymer thus prepared may be applied as a layer on a substrate. Electronic components with layers prepared with the polymer of the invention show better properties.
    Type: Application
    Filed: January 24, 2002
    Publication date: February 6, 2003
    Inventors: Wolter Ten Hoeve, Margaretha Maria De Kok, Bart-Hendrik Huisman, Peter Tobias Herwig, Albert Jos Jan Marie Van Breemen
  • Methods and compositions for ameliorating the symptoms of sepsis
    Patent number: 6495332
    Abstract: The present invention concerns a method of treating sepsis comprising administering a therapeutically effective amount of anti-CD14 antibody molecules. A therapeutic composition comprising anti-CD14 antibody molecules in a pharmaceutically acceptable excipient is also contemplated.
    Type: Grant
    Filed: October 2, 2001
    Date of Patent: December 17, 2002
    Assignees: The Sripps Research Institute, The Rockefeller University
    Inventors: Richard Ulevitch, Peter Tobias, Samuel D. Wright, John C. Mathison
  • Display device
    Patent number: 6433357
    Abstract: Display device in which switching elements (5) are realized in an organic semiconductor layer. Mutual insulation of the elements and pixels is obtained either electrically by applying depletion via voltages to a guard line (4) or physically by making parts of the organic semiconductor layer insulating.
    Type: Grant
    Filed: August 22, 2000
    Date of Patent: August 13, 2002
    Assignee: Koninklijke Philips Electronics N.V.
    Inventors: Karel Elbert Kuijk, Marco Matters, Peter Tobias Herwig, Thomas Cleophas Theodorus Geuns
  • Methods and compositions for ameliorating the symptoms of sepsis
    Publication number: 20020034509
    Abstract: The present invention concerns a method of treating sepsis comprising administering a therapeutically effective amount of anti-CD14 antibody molecules. A therapeutic composition comprising anti-CD14 antibody molecules in a pharmaceutically acceptable excipient is also contemplated.
    Type: Application
    Filed: October 2, 2001
    Publication date: March 21, 2002
    Inventors: Richard Ulevitch, Peter Tobias, Samuel D. Wright, John C. Mathison
  • Monoclonal antibodies immunoreactive with lipopolysaccharide binding protein (LBP) and methods of their use
    Publication number: 20010029292
    Abstract: The present invention concerns a method of treating LBP-mediated LPS-induced myeloid cell activation comprising administering a therapeutically effective amount of an anti-LBP monoclonal antibody molecule. A therapeutic composition comprising anti-LBP antibody molecules in a pharmaceutically acceptable excipient is also contemplated.
    Type: Application
    Filed: May 15, 2001
    Publication date: October 11, 2001
    Applicant: The Scripps Research Institute
    Inventors: Theo Kirkland, Peter Tobias, Richard Ulevitch, Ann Moriarty, Didier Leturcq
  • Methods and compositions for ameliorating the symptoms of sepsis
    Patent number: 6297049
    Abstract: The present invention concerns a method of treating sepsis comprising administering a therapeutically effective amount of anti-CD14 antibody molecules. A therapeutic composition comprising anti-CD14 antibody molecules in a pharmaceutically acceptable excipient is also contemplated.
    Type: Grant
    Filed: April 3, 2000
    Date of Patent: October 2, 2001
    Assignee: The Scripps Research Institute
    Inventors: Richard Ulevitch, Peter Tobias, Samuel D. Wright, John C. Mathison
  • Monoclonal antibodies immunoreactive with lipopolysaccharide binding protein (LBP) and methods of their use
    Patent number: 6232080
    Abstract: The present invention concerns a method of treating LBP-mediated LPS-induced myeloid cell activation comprising administering a therapeutically effective amount of an anti-LBP monoclonal antibody molecule. A therapeutic composition comprising anti-LBP antibody molecules in a pharmaceutically acceptable excipient is also contemplated.
    Type: Grant
    Filed: May 19, 1998
    Date of Patent: May 15, 2001
    Assignee: The Scripps Research Institute
    Inventors: Theo Kirkland, Peter Tobias, Richard Ulevitch, Ann Moriarty, Didier Leturcq
  • Methods and compositions for ameliorating the symptoms of sepsis
    Patent number: 6045795
    Abstract: The present invention concerns a method of treating sepsis comprising administering a therapeutically effective amount of anti-CD14 antibody molecules. A therapeutic composition comprising anti-CDl4 antibody molecules in a pharmaceutically acceptable excipient is also contemplated.
    Type: Grant
    Filed: August 5, 1997
    Date of Patent: April 4, 2000
    Assignee: The Scripps Research Institute
    Inventors: Richard Ulevitch, Peter Tobias, Samuel D. Wright, John C. Mathison
  • Monoclonal antibodies immunoreactive with lipopolysaccharide binding protein (LBP) and methods of their use
    Patent number: 5753504
    Abstract: The present invention concerns a method of treating LBP-mediated LPS-induced myeloid cell activation comprising administering a therapeutically effective amount of an anti-LBP monoclonal antibody molecule. A therapeutic composition comprising anti-LBP antibody molecules in a pharmaceutically acceptable excipient is also contemplated.
    Type: Grant
    Filed: July 15, 1996
    Date of Patent: May 19, 1998
    Assignee: The Scripps Research Institute
    Inventors: Theo Kirkland, Peter Tobias, Richard Ulevitch, Ann Moriarty, Didier Leturcq
  • Methods and compositions for ameliorating the symptoms of sepsis
    Patent number: 5730980
    Abstract: The present invention concerns a method of treating CD14-mediated host inflammatory response to LPS often associated with sepsis comprising administering a therapeutically effective amount of anti-CD14 antibody molecules. A therapeutic composition comprising anti-CD14 antibody molecules in a pharmaceutically acceptable excipient is also contemplated.
    Type: Grant
    Filed: October 25, 1994
    Date of Patent: March 24, 1998
    Assignee: The Scripps Research Institute
    Inventors: Richard Ulevitch, Peter Tobias, Samuel D. Wright, John C. Mathison
  • Methods for identifying inhibitors of LPS-mediated LBP binding
    Patent number: 5705398
    Abstract: The present invention describes a rapid method for the identification of compounds/reagents which inhibit lipopolysaccharide (LPS) binding to LPS binding protein (LBP), and kits for practicing the method.
    Type: Grant
    Filed: March 2, 1994
    Date of Patent: January 6, 1998
    Assignee: The Scripps Research Institute
    Inventors: Douglas N. Mintz, Peter Tobias, Richard Ulevitch
  • Acute phase protein modulating endotoxic activity of lipopolysaccharides, assay methods and polypeptides
    Patent number: 5245013
    Abstract: A lipopolysaccharide binding protein is disclosed as are an assay method, polypeptides and antibodies related to that binding protein. The binding protein: (a) is present in impure form in acute phase serum, but is substantially absent from normal serum; (b) binds to Gram-negative bacterially secreted lipopolysaccharide in vitro in the serum of the animal treated; (c) retards in vitro binding of the lipopolysaccharide to high density lipoprotein present in the normal serum of the animal host; and (d) immunoreacts with antibodies raised to a polypeptide having the amino acid residue sequence, from left to right and in the direction from amino-terminus to carboxy-terminus, or ##STR1## wherein each of said parenthesized amino acid residues in an alternative to the immediately preceding residue in said sequence.
    Type: Grant
    Filed: June 16, 1989
    Date of Patent: September 14, 1993
    Inventors: Richard Ulevitch, Peter Tobias
  • Sample box
    Patent number: D431775
    Type: Grant
    Filed: August 30, 1999
    Date of Patent: October 10, 2000
    Assignee: Tyrolit Schleifmittelwerke Swarovski, K.G.
    Inventors: Hermann Plattner, Monika E. Oberleit, Ute Nalter, Wolfgang Huber, Peter Tobias, Harald Helletsberger, Anselm Kaspar